Introduction
Pulse pressure (PP) -calculated by subtracting diastolic from systolic arterial pressurereflects the complex haemodynamic interplay between stroke volume, heart rate, aortic compliance and peripheral vascular tone. In the general medical population, elevated pulse pressure is strongly associated with increased cardiovascular risk for coronary heart disease, [1] [2] [3] cardiac failure, [4] [5] [6] [7] [8] atrial fibrillation 9 and all-cause cardiovascular mortality. 1, [10] [11] [12] [13] This longestablished relationship is independent of normotensive or hypertensive status. 6 In marked contrast, lower pulse pressure in patients with cardiac failure is associated with reduced cardiac index, 14 increased levels of natriuretic peptide 15 and accelerated morbidity/mortality. 8, 9, 16, 17 Notably, in patients with heart failure originating from a nonischaemic aetiology, pulse pressure appears to be closely correlated with stroke volume. 18 The MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) meta-analysis identified pulse pressure ≤53mmHg as a robust independent predictor of mortality in 27046 patients from 22 separate studies/trials in cardiac failure. 16 Deconditioned surgical patients share similar cardiovascular and autonomic features with cardiac failure patients, including reduced cardiopulmonary reserve. 19 Low preoperative pulse pressure may therefore also be associated with increased risk of postoperative morbidity in higher-risk surgical patients.
In this prospective multi-centre cohort study, we hypothesized that the pulse pressure threshold identified in cardiac failure patients (≤53mmHg) was similarly associated with postoperative morbidity in higher risk surgical patients referred for cardiopulmonary exercise testing as part of their routine preoperative assessment. By focussing on low pulse pressure in this analysis, we provide novel data highlighting the striking physiological similarities between patients with overt cardiac failure and deconditioned surgical patients.
METHODS
We conducted a secondary analysis of a prospective, multicentre observational cohort study of high-risk patients undergoing cardiopulmonary exercise testing prior to major non-cardiac Cardiopulmonary exercise testing.
Patients underwent cardiopulmonary exercise testing on an electronic cycle ergometer using an incremental ramp protocol to maximal tolerance, having continued their normal cardiovascular medications up to and including the day of the test. Equipment was calibrated before each test using standard reference gases. Arterial blood pressure was measured (sitting) at rest before exercise. Continuous 12-lead electrocardiography and breath-by-breath gas exchange analysis were performed throughout testing. All patients were instructed to continue cycling until symptom-limited fatigue occurred. Pulse pressure was calculated retrospectively from routine measurements of arterial systolic and diastolic pressure.
Anaerobic threshold (AT) was determined by two independent assessors blinded to pulse pressure and according to published guidelines using the modified V-slope method and confirmed by ventilatory equivalents for carbon dioxide ( E/ CO2) and oxygen ( E/ O2). i.e. suggestive of infectious morbidity.
Transthoracic echocardiography.
As TTE was not part of the study protocol, only data from patients at UCLH referred for transthoracic echocardiography (Vivid E9 or GE Vivid I, GE Healthcare, UK) as part of their preoperative assessment were assessed. Echocardiography was undertaken by technicians blinded to the patients' participation in this study.
Outcome measures
The primary explanatory outcome was any postoperative complication, assessed using the Postoperative Morbidity Survey (POMS) 22 by postoperative day 5. The presence of morbidity from any of the nine domains of the Postoperative Morbidity Survey was considered to constitute the presence of significant morbidity by postoperative day five. Secondary clinical outcomes were time to become morbidity free and hospital length of stay. Cardiopulmonary impairment associated with PP was assessed primarily by predicted oxygen pulse, a robust surrogate for left ventricular stroke volume. 21 In addition, we analysed other parameters derived during cardiopulmonary exercise (heart rate, anaerobic threshold, E/ CO2), expressed as % predicted population normal values corrected for age and gender, where applicable. 21 
Statistical analysis
Categorical data are summarized as absolute values (percentage). Continuous data that follow a normal distribution are presented as mean (standard deviation) and continuous data that follow a non-normal distribution are presented as median (interquartile range). To assess whether low or high pulse pressure according to a pre-defined threshold of pulse pressure ≤53mmHg was associated with morbidity, we divided the cohort into two groups according to this threshold. The relationship between pulse pressure ≤53mmHg and postoperative morbidity were compared using the Fishers exact test for trend. Continuous data were analyzed using ANCOVA (controlling for age, gender, body-mass index), with post-hoc Tukey Kramer tests to identify within and between factor differences. To determine whether observed associations were as a result of confounding, we repeated the analysis using a one-way, hierarchical forward switching logistic regression model, 23 which including the following covariates that are associated with postoperative morbidity: age, 
Power calculation
The primary clinical outcome was POMS-defined morbidity by postoperative day 5. We estimated the sample size using survival curves from several pulse pressure studies in heart failure (totalling 27046 patients in 22 separate heart failure studies), where patients with pulse pressure ≥53mmHg have 20% lower mortality (35% mortality versus 55% mortality in patients with pulse pressure ≤53mmHg). 16 POMS-defined morbidity is at least 50% by postoperative day 5 in similar higher-risk patient populations, 24, 25 and correlates with posthospital mortality. 26 Therefore, assuming that patients with pulse pressure ≥53mmHg would sustain 50% relative reduction in POMS-defined morbidity, ≥569 patients would be required to detect a clinically relevant reduction of 20% fewer patients being free of morbidity on postoperative day 5 (α=0.01; β=0.9).
RESULTS

Patient characteristics.
Figure 1 summarizes patient recruitment at preoperative assessment and progression to surgery. Pulse pressure was calculated in 821 patients on the day of cardiopulmonary exercise testing, of whom 660 proceeded to surgery (Table 1) . Mean (SD) preoperative pulse pressure was 61±19 mmHg. 302/821 (36.7%) patients had pulse pressure ≤53mmHg. Older age and higher systolic blood pressure were the only factors associated with pulse pressure ≥53mmHg ( Table 2 ). Predicted morbidity, as calculated by POSSUM score for different surgical procedures, was similar between pulse pressure groups (p=0.16 for interaction between type of surgical procedure and pulse pressure ≤53mmHg; Supplementary Table 3 ).
Primary analysis: pulse pressure and postoperative outcome.
There were 260/660 patients with pulse pressure ≤53mmHg who proceeded to surgery.
Patients with pulse pressure ≤53mmHg were more likely to sustain postoperative morbidity in the first five days after surgery (odds ratio:2.24 (1.29-3.38); p<0.001), as reflected by the time to become morbidity free (p=0.05, by log-rank test; Figure 2 ). Although sustaining any postoperative morbidity was common in this higher-risk population (87.6%), patients with pulse pressure ≤53mmHg were more likely to sustain pulmonary (50%; odds ratio: Figure 1) . In-hospital mortality (1.6%) was similar between pulse pressure groups (odds ratio:1.08 (0.35-3.32). Lower pulse pressure (≤53 mmHg) is an independent predictor of mortality in patients with reduced ejection fraction heart failure, but particularly in those with a systolic blood pressure <140 mmHg. 8 In our study, we found that patients with pulse pressure ≤53mmHg alone, or in combination with a systolic arterial pressure threshold <140mmHg (219/243), had a similar incidence of postoperative morbidity by postoperative day 5 (OR:1.94 (0.25-15.2); p=0.9).
Pulse pressure and cardiovascular performance.
Mean anaerobic threshold across the whole population was 11.8ml.kg. We also observed higher resting heart rate, lower predicted peak oxygen consumption but similar E/ CO2 ratio when preoperative pulse pressure ≤53mmHg (Table 1) . In an exploratory analysis, transthoracic echocardiography in a subset of 47 patients found similar
proportions of patients with preserved ejection fraction (≥60%) and lower pulse pressure (p=0.66; Supplementary Table 5) .
DISCUSSION
This multi-centre prospective study shows that pulse pressure, a simple, inexpensive, and readily available clinical index, provides additional useful preoperative information in surgical patients who are deconditioned with low cardiopulmonary reserve. Mirroring the heart failure literature, we found that lower pulse pressure was independently associated with more postoperative morbidity. In particular, the diagnostic utility of pulse pressure ≤53mmHg, as identified from meta-analysis of >27,000 patients enrolled into heart failure trials, 16 appears to similarly apply to surgical patients without a formal diagnosis of heart failure.
This study recruited high-risk patients with low cardiopulmonary reserve (as indicated by low anaerobic threshold) and high predicted postoperative morbidity as adjudged from POSSUM scores. Perioperative clinicians routinely deem patients as being at higher-risk "by eye" -even though the mechanistic/ physiological reasons for this intuitive decision are not readily apparent. Although patients with higher pulse pressure appeared to be relatively "protected", our data also highlight that patients with lower pulse pressure may have advanced cardiovascular impairment as a result of less intense, or absent, primary cardiovascular prevention. These observations reinforce the opportunity that cardiopulmonary exercise testing affords to characterize and understand the cardiopulmonary function of higher risk surgical patients, as several perioperative reports have demonstrated.
Cardiovascular regulation and performance in patients with heart failure and low pulse pressure is complex, with left ventricular ejection fraction playing a critical influence.
Apparently paradoxically-and in contrast to the general population-heart failure patients with reduced pulse pressure have worse clinical outcomes, including accelerated mortality.
These data suggest that reduced cardiac function and lower stroke volume are the chief determinants of lower pulse pressure in heart failure characterized by impaired ejection fraction. However, this contrasts with extensive and robust observations on pulse pressure in the general population, where higher (rather than lower) pulse pressure has consistently been linked to adverse outcomes. This qualitative shift in the association of pulse pressure with mortality is most likely explained by elevated arterial stiffness driving haemodynamic performance prior to the relative failure of the left ventricle to counteract high afterload over the long-term. The progressive reduction in left ventricular performance is promoted by ischaemia and/or fibrosis. However, this picture is further complicated by the absence of the lower pulse pressure relationship and outcomes in patients with preserved ejection fraction heart failure, in striking contrast to reduced ejection fraction heart failure. 8 Our data suggest that although the vast majority of patients did not have a clinical diagnosis of heart failure, they exhibited low cardiopulmonary reserve characterized by reduced left ventricular stroke volume (low predicted oxygen pulse) in conjunction with low pulse pressure. This is perhaps surprising, given the higher incidence of preserved ejection fraction heart failure in the general population. Nevertheless, deconditioned surgical patients share reduced cardiovascular reserve that is strikingly similar to that observed in heart failure patients. 19 Comprehensive echocardiography (which was logistically and financially beyond the scope of this study cohort) and B-type natriuretic peptide data are likely to help clarify these findings in both heart failure and perioperative populations.
Lower pulse pressure was associated with delayed resolution of postoperative morbidity. The associations we found between lower PP and specific morbidities five days after major surgery offer potential mechanistic insights into the evolution of postoperative complications, which usually cluster. We cannot exclude that pulmonary morbidity (essentially defined as additional oxygen requirement) at this timepoint is a by-product of the presence of persistent gastrointestinal dysfunction, in addition to ongoing requirements for parenteral analgesia. Impaired cardiovascular performance is strongly linked to renal and gastrointestinal dysfunction postoperatively; in patients with low pulse pressure, poorer cardiac output would be likely to fuel renal and/or gastrointestinal hypoperfusion. Pain may also be independently associated with this lower pulse pressure phenotype, since multiple mechanisms link hypertensive remodelling with lower analgesic thresholds. [27] [28] [29] Significant strengths of this adequately powered observational study include the prospective, multicentre data collection. Study personnel and patients were blinded to pulse pressure data linked to outcomes. The limited amount of detailed echocardiographic data, including assessment of diastolic function, precludes further insights into whether the reduced/ preserved ejection fraction observations made in the heart failure literature extend into the perioperative arena. Nevertheless, combining pulse pressure measurement with contemporaneous cardiopulmonary exercise testing provides detailed (and arguably richer) dynamic physiological data than resting echocardiography alone. The use of N-terminal brain natriuretic peptide would have helped further clarify whether patients with low pulse pressure exhibit clear evidence for cardiac failure, independent of more extensive and time-consuming investigations. The high incidence of morbidity by postoperative day 5 reinforces the highrisk characteristics of the patients and surgery undertaken in this study, but possibly dilutes the discriminatory power of pulse pressure as a robust predictor. Although POMS correlates with longer-term mortality, 26 the lack of 90-day mortality data (as routinely used in National Bowel Cancer Audit annual reports) is a limitation. The lack of troponin measurements would likely clarify whether low pulse pressure confers greater perioperative risk of myocardial injury, since the cardiovascular domains of POMS are particularly insensitive.
The generalisability of these data is likely limited to deconditioned, older higher-risk patients, since elevated-rather than reduced-pulse pressure is associated with cardiovascular risk in the wider general medical population.
In summary, our findings suggest that lower pulse pressure in higher-risk surgical patients merits the consideration of an extensive preoperative assessment centred on cardiovascular performance. These pulse pressure data suggest that cardiopulmonary exercise testing may further objectively refine that assessment, since these patients share a strikingly similar cardiovascular phenotype to that described in reduced ejection fraction heart failure.
There is a growing recognition that subtypes of heart failure are likely to require different treatment regimens. 30 In contrast to heart failure with preserved ejection fraction, major progress has been made in improving survival from reduced ejection fraction heart failure. Kaplan-Meier plot depicting time to become morbidity free, stratified by preoperative pulse pressure >53mmHg versus <53mmHg. Unadjusted log-rank analysis showed that PP≤53mmHg was associated with delayed resolution of morbidity (hazard ratio: 1.62
(95%CI:1.14-2.32); p=0.05). 
